Rigontec GmbH

Rigontec GmbH

Rigontec GmbH

Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options
Founded
2014
Raised
$35.2M
Follow us
Alexa global traffic share
Latest funding
Team Size
1–10
Employees
Location
Headquarters
PE HUB

Merck to buy VC-backed Rigontec

Health Funding
rigontec

Rigontec GmbH – A Dual Approach To Treat Cancer is a privately held biopharmaceutical company that develops RNA-based im...

Health Science Funding
€15,000,000 Venture capital (Series A)
FinSMEs

Rigontec Raises €15M in Third Closing of Series A Funding

Funding Health